Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company?) is pleased to announce that it has engaged Guy Ricciardulli for services related to claims for damages...
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company?) announces the multicenter publication of independent research which reports an association between...
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) (?Nanobac? or ?the Company?) announces that scientists at the Baylor College of Medicine, working under a collaborative agreement...
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP)?("Nanobac" or "the Company") announces that its proprietary CE marked Nano-Capture ELISA assay and Nano-Sero IgG ELISA assay currently...
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") announces that it has completed Phase I of its 2006 scientific plan advancing Nanobac?s claim that...
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") announces the publication of correspondence in the June 23, 2007 issue of The Lancet that demonstrates new...
Nanobac Pharmaceuticals, Inc. (OTCBB:NNBP) ("Nanobac" or "the Company?) announces that scientists at Mayo Clinic, working under a collaborative agreement with Nanobac have...
Nanobac Pharmaceuticals, Inc. (OTCBB:NNBP) announces scientists at Mayo, working under a collaborative agreement with Nanobac Pharmaceuticals Inc., have published an article in...
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") announces new evidence that may help solve one of the great puzzles of 21st century medicine was published...
First graph of release, link to view video should read: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5265147 The corrected release reads: STOCKHOLDER CONFERENCE CALL...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 2000 | 1.0E-6 | CS |
26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 714 | 1.0E-6 | CS |
52 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 65310 | 1.0E-6 | CS |
156 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 91535 | 2.74E-6 | CS |
260 | -0.000199 | -99.5 | 0.0002 | 0.0076 | 1.0E-6 | 316033 | 0.001034 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관